Published 2 days ago • loading... • Updated 2 days ago
Gut Immune Cells May Improve Multiple Sclerosis Treatment Outcomes
The treatment also recruits protective gut-derived regulatory B cells into the bloodstream and central nervous system, and higher factor levels were tied to better outcomes.
B-cell depletion therapies, in which B cells of the immune system, which may drive disease activity in multiple sclerosis (MS), are temporarily removed, have contributed significantly to improved treatment for patients in recent years.